Nodal Therapeutics

Silver Spring, United States

Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.

$500K raised

May 2026

Seed

Finance Financial Services Venture Capital

Top Investors

TEDCO

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nodal Therapeutics

How much funding has Nodal Therapeutics raised?

Nodal Therapeutics has raised $500K in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are Nodal Therapeutics's investors?

Nodal Therapeutics's investors include TEDCO.

Where is Nodal Therapeutics headquartered?

Nodal Therapeutics is headquartered in Silver Spring, United States.

What does Nodal Therapeutics do?

Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.

What stage is Nodal Therapeutics at?

Nodal Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 28, 2026.

MLA

"Nodal Therapeutics — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/nodal-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Nodal Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nodal-therapeutics

Wikipedia (cite web)

{{cite web |title=Nodal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nodal-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 28, 2026.

Similar Companies in Finance